Question

When will the FDA or EMA first approve a drug for the treatment of obesity that causes >25% weight loss?

3 comments3

Total Forecasters15

Community Prediction2028-12

Make a Prediction

My Prediction

community

lower 25%

median

upper 75%

>2050-01

...

2026-10

2028-12

2031-09

1.9%

Authors:

casens

Opened:

Closes:

Scheduled resolution:

Health & Pandemics

Anti-obesity medication

Food and Drug Administration

Gastroenterology

Will the FDA or EMA withdraw approval of Semaglutide for the treatment of obesity by 2027?

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

81%

Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?

60%

Comments

? comments

Authors:

casens

Opened:

Closes:

Scheduled resolution:

Health & Pandemics

Anti-obesity medication

Food and Drug Administration

Gastroenterology

The risks of taking Ozempic that are only now emerging and make me worry - even though it CAN be a weight loss fix, by DR EMILY LEEMING

Daily Mail•Oct 2, 2024

GLP-1 Agonists May Help Treatment of Mental Illness and Substance Use

Psychology Today•Oct 2, 2024

Mounjaro, Zepbound shortage eases as supplies of weight loss drug rebound

USA Today•Oct 4, 2024

Learn more about Metaculus NewsMatch

Will the FDA or EMA withdraw approval of Semaglutide for the treatment of obesity by 2027?

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

81%

Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?

60%

MetaculusM

🚀Metaculus Open-Source Rewrite is Live!

When will the FDA or EMA first approve a drug for the treatment of obesity that causes >25% weight loss?

Make a Prediction

Will the FDA or EMA withdraw approval of Semaglutide for the treatment of obesity by 2027?

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?

Comments

Will the FDA or EMA withdraw approval of Semaglutide for the treatment of obesity by 2027?

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?

Will the FDA or EMA withdraw approval of Semaglutide for the treatment of obesity by 2027?

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?

Will the FDA or EMA withdraw approval of Semaglutide for the treatment of obesity by 2027?

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?